CompletedPhase 3NCT00630812
Long Term Administration of Inhaled Mannitol in Cystic Fibrosis
Studying Cystic fibrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Syntara
- Principal Investigator
- Moira L Aitken, MDUniversity of Washington Medical Centre, Seattle WA
- Intervention
- inhaled mannitol(drug)
- Enrollment
- 318 enrolled
- Eligibility
- 6 years · All sexes
- Timeline
- 2008 – 2010
Study locations (30)
- University of Arizona, Tucson, Arizona, United States
- Central Connecticut Cystic Fibrosis Center, Hartford, Connecticut, United States
- Nemours Childrens Clinic, Jacksonville, Florida, United States
- Batchelor Children's Research Institute - University of Miami, Miami, Florida, United States
- Nemours Children's Clinic Orlando, Orlando, Florida, United States
- St Lukes CF Center of Idaho, Idaho City, Idaho, United States
- Northwestern Memorial Hospital, Chicago, Illinois, United States
- Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States
- Maine Pediatric Specialty Group, Portland, Maine, United States
- John Hopkins, Baltimore, Maryland, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- University of Missouri, Columbia, Missouri, United States
- Nebraska Medical Center - Nebraska Regional CF Center, Omaha, Nebraska, United States
- Women and Childrens Hospital of Buffalo, Buffalo, New York, United States
- The Toledo Hospital and Toledo Childrens Hospital, Toledo, Ohio, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
ethica Clinical Research Inc. · Europe: KasaConsult bvba, Hoegaarden, Belgium · Resolution Latin America
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00630812 on ClinicalTrials.govOther trials for Cystic fibrosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT04530383Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel FunctionUniversity of Kansas Medical Center
- RECRUITINGPHASE2NCT07450547Phase 2 Study to Assess the Safety and Efficacy of ANG003Anagram Therapeutics, Inc.
- RECRUITINGPHASE1NCT07437105Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy ParticipantsVertex Pharmaceuticals Incorporated
- RECRUITINGNANCT07436351ACT With CF Self-Help ToolkitThomas Jefferson University
- RECRUITINGNANCT07314229Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-IvacaftorUniversity Hospital, Lille
- RECRUITINGNCT07369414Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-control Study of Exposure Risk at HomeResearch Center Borstel
- RECRUITINGNCT07083557Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)Bettina Mittendorfer
- RECRUITINGNCT07505797ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)iSono Health, Inc.